COMPOSITION COMPRISINGSALVIA MILTIORRHIZA

• Main Authors: KIM, Nu Ree, YOON, Joo Seog, SON, Jeong Hwan
• Format: Patent
• Language: English; French; German
• Published: 03.11.2021
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

Disclosed is a composition for preventing, ameliorating or treating visceral fat obesity containing aSalvia miltiorrhizaradix extract having excellent activity of reducing visceral fat.Disclosed is a composition for preventing, ameliorating or treating visceral fat obesity containing an extract ofSalvia miltiorrhizaradix that has efficacy specific for visceral fat when administered to obese model animal mice that have obesity caused by decreased leptin secretion and diet-induced obesity (DIO) mice in which obesity is induced using a high-fat diet.Disclosed is a composition for preventing, ameliorating or treating visceral fat obesity containing an S.miltiorrhizaextract, wherein the S.miltiorrhizaextract inhibits the production of triglyceride (TG) in liver tissue and the blood, indicating that the S.miltiorrhizaextract has inhibitory activity on visceral-fat-type obesity, and the S.miltiorrhizaextract decreases the expression of ALT, LDH, BUN, FFA or HbA1Cin the blood and reduces visceral fat, as can be seen from MRI and MRS.